CU20110033A7 -
DAA-PIRIDINA AS BINDING WITH THE PERIPHERAL RECEIVER OF BENZODIAZEPINA FOR IMAGE DIAGNOSIS AND PHARMACEUTICAL TREATMENT
- Google Patents
DAA-PIRIDINA AS BINDING WITH THE PERIPHERAL RECEIVER OF BENZODIAZEPINA FOR IMAGE DIAGNOSIS AND PHARMACEUTICAL TREATMENT
Info
Publication number
CU20110033A7
CU20110033A7CU20110033ACU20110033ACU20110033A7CU 20110033 A7CU20110033 A7CU 20110033A7CU 20110033 ACU20110033 ACU 20110033ACU 20110033 ACU20110033 ACU 20110033ACU 20110033 A7CU20110033 A7CU 20110033A7
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma AgfiledCriticalBayer Schering Pharma Ag
Priority to CU20110033ApriorityCriticalpatent/CU20110033A7/en
Publication of CU20110033A7publicationCriticalpatent/CU20110033A7/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Compuestos nuevos adecuados para marcar o ya marcados con 18F, con métodos para preparar tales compuestos, con composiciones que comprenden dichos compuestos, con conjuntos de elementos que comprenden dichos compuestos o composiciones y con los usos de dichos compuestos, composiciones o conjuntos de elementos en terapias y para diagnóstico por imágenes mediante tomografía de emisión de positrones (PET).New compounds suitable for labeling or already labeled with 18F, with methods for preparing such compounds, with compositions comprising said compounds, with sets of elements comprising said compounds or compositions and with the uses of said compounds, compositions or sets of elements in therapies and for imaging diagnosis by positron emission tomography (PET).
CU20110033A2011-02-042011-02-04
DAA-PIRIDINA AS BINDING WITH THE PERIPHERAL RECEIVER OF BENZODIAZEPINA FOR IMAGE DIAGNOSIS AND PHARMACEUTICAL TREATMENT
CU20110033A7
(en)
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
Compounds derived from 1,2,4-triazole; pharmaceutical composition; procedure for the preparation of their procursors and the use as modulators of nuclear transport in the treatment of diseases such as cancer.
Compounds derived from substituted pyrrole; preparation procedure; pharmaceutical composition that contains them; pharmaceutical combination; use to treat diseases such as cancers and immune system diseases.
Compounds derived from pyrrolopyrimidine and purine, and their pharmaceutically acceptable salts; pharmaceutical composition comprising them, useful for the treatment of abnormal cell growth, such as cancer.
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
Compounds derived from spiro [bicyclo [3.1.0] hexane-4,1’-cyclopropane], mglu2 / 3 receptor agonists; and pharmaceutical composition that includes them.